J Pharma Co Ltd (520A)

Currency in JPY
392.00
+43.00(+12.32%)
Delayed Data·
Unusual trading volume
520A is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
333.00426.00
52 wk Range
260.00880.00
Key Statistics
Bid/Ask
392.00 / 393.00
Prev. Close
349
Open
350
Day's Range
333-426
52 wk Range
260-880
Volume
1.39M
Average Volume (3m)
109.55K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
520A Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Earnings

Latest Release
Aug 12, 2026
EPS / Forecast
-31.22 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

520A Income Statement

Compare 520A to Peers and Sector

Metrics to compare
520A
Peers
Sector
Relationship
P/E Ratio
−2.9x−4.7x−0.4x
PEG Ratio
0.420.090.00
Price/Book
-0.7x2.6x
Price / LTM Sales
-1.5x3.1x
Upside (Analyst Target)
-69.2%49.6%
Fair Value Upside
Unlock27.3%7.1%Unlock

J-Pharma Co., Ltd. is engaged in the research and development of pharmaceutical drugs in Japan. The company researches and develops drugs targeting solute carrier (SLC) transporters, with emphasis on the LAT1 amino acid transporter. It is developing several compounds for various medical indications, including nanvuranlat (JPH203), a novel small-molecule compound identified as a selective inhibitor of LAT1 and provide treatment for biliary tract cancer, as well as for colorectal cancer; JPH034 is characterized as high brain penetrance and development for disorders of the central nervous system, including non-relapsing secondary progressive multiple sclerosis and glioma; and JPT-0008 for solid tumor, autoimmune diseases, and rare diseases. It also conducting clinical trail for biliary tract cancer and JPH034. The company was founded in 2005 and is based in Minato, Japan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
36.00K0.20%14.08M
Other Institutional Investors
16.14M89.72%6.31B
Public Companies & Retail Investors
1.81M10.08%708.75M
Total
17.98M100.00%7.03B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
JIC Venture Growth Fund 111.24%2,021,325790,338
Japan Investment Corporation11.24%2,021,325790,338

People Also Watch

151.55
LAMR
+0.03%
280.0
543A
-0.71%
1,481.50
HRMS
-3.30%
52.58
MKC
-2.27%

FAQ

What Is the J Pharma (520A) Stock Price Today?

The J Pharma stock price today is 392.00 JPY.

What Stock Exchange Does J Pharma Trade On?

J Pharma is listed and trades on the Tokyo Stock Exchange.

What Is the Stock Symbol for J Pharma?

The stock symbol for J Pharma is "520A."

What Is the J Pharma Market Cap?

As of today, J Pharma market cap is 6.28B JPY.

What Is J Pharma's Earnings Per Share (TTM)?

The J Pharma EPS (TTM) is -195.08.

From a Technical Analysis Perspective, Is 520A a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has J Pharma Stock Split?

J Pharma has split 0 times.

What is the current trading status of J Pharma (520A)?

As of Sep 04, 2026, J Pharma (520A) is trading at a price of 392.00 JPY, with a previous close of 349.00 JPY. The stock has fluctuated within a day range of 333.00 JPY to 426.00 JPY, while its 52-week range spans from 260.00 JPY to 880.00 JPY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.